Ziegler Annemarie, Seemayer Christian A, Hinterberger Marc, Vogt Peter, Bigosch Colette, Gautschi Oliver, Tornillo Luigi, Betticher Daniel C, Moch Holger, Stahel Rolf A
Clinic and Policlinic of Oncology, Laboratory of Molecular Oncology, University Hospital, Haeldeliweg 4, CH-8044 Zurich, Switzerland.
Lung Cancer. 2007 Sep;57(3):282-91. doi: 10.1016/j.lungcan.2007.03.025. Epub 2007 May 21.
The association of simian virus 40 (SV40) with malignant pleural mesothelioma is currently under debate. In some malignancies of viral aetiology, viral DNA can be detected in the patients' serum or plasma. To characterize the prevalence of SV40 in Swiss mesothelioma patients, we optimized a real-time PCR for quantitative detection of SV40 DNA in plasma, and used a monoclonal antibody for immunohistochemical detection of SV40 in mesothelioma tissue microarrays. Real-time PCR was linear over five orders of magnitude, and sensitive to a single gene copy. Repeat PCR determinations showed excellent reproducibility. However, SV40 status varied for independent DNA isolates of single samples. We noted that SV40 detection rates by PCR were drastically reduced by the implementation of strict room compartmentalization and decontamination procedures. Therefore, we systematically addressed common sources of contamination and found no cross-reactivity with DNA of other polyomaviruses. Contamination during PCR was rare and plasmid contamination was infrequent. SV40 DNA was reproducibly detected in only 4 of 78 (5.1%) plasma samples. SV40 DNA levels were low and not consistently observed in paired plasma and tumour samples from the same patient. Immunohistochemical analysis revealed a weak but reproducible SV40 staining in 16 of 341 (4.7%) mesotheliomas. Our data support the occurrence of non-reproducible SV40 PCR amplifications and underscore the importance of proper sample handling and analysis. SV40 DNA and protein were found at low prevalence (5%) in plasma and tumour tissue, respectively. This suggests that SV40 does not appear to play a major role in the development of mesothelioma.
猿猴病毒40(SV40)与恶性胸膜间皮瘤之间的关联目前仍存在争议。在一些由病毒引起的恶性肿瘤中,可在患者的血清或血浆中检测到病毒DNA。为了确定SV40在瑞士间皮瘤患者中的流行情况,我们优化了一种实时PCR方法用于定量检测血浆中的SV40 DNA,并使用单克隆抗体在间皮瘤组织微阵列中进行SV40的免疫组织化学检测。实时PCR在五个数量级上呈线性,对单个基因拷贝敏感。重复PCR测定显示出极好的可重复性。然而,单个样本的独立DNA分离物的SV40状态有所不同。我们注意到,通过实施严格的房间分区和去污程序,PCR检测SV40的比率大幅降低。因此,我们系统地排查了常见的污染源,未发现与其他多瘤病毒DNA有交叉反应。PCR过程中的污染很少见,质粒污染也不常见。在78份血浆样本中,只有4份(5.1%)可重复检测到SV40 DNA。SV40 DNA水平较低,且在同一患者的配对血浆和肿瘤样本中并非始终能检测到。免疫组织化学分析显示,在341例间皮瘤中有16例(4.7%)呈现微弱但可重复的SV40染色。我们的数据支持了不可重复的SV40 PCR扩增的存在,并强调了正确处理和分析样本的重要性。在血浆和肿瘤组织中分别发现SV40 DNA和蛋白质的低流行率(5%)。这表明SV40似乎在间皮瘤的发生发展中不起主要作用。